UNSPSC 51413905: Flosatidil

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19S89CMO38. European Medicines Agency schedules Flosatidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07653MIG. Flosatidil generally arises in the molecular formula C26H34F3N3O3S.

UNSPSC 51413905 Flosatidil, a Commodity code, covers emergency pharmaceutical supply procurement for state and local fire, rescue, and emergency medical services operations. The recent activity under this code reflects the purchase of critical medications used in advanced life support protocols — specifically, vasodilators, vasoconstrictors, and antiarrhythmic agents required by paramedic and emergency responder teams during acute cardiac and hemodynamic crises. State and local fire departments and emergency services agencies are the primary buyers under this code, procuring these medications in sealed-bid or competitive RFQ processes to maintain inventory compliance and clinical readiness standards.

The City of Tampa's Purchasing Department posted one representative recent opportunity: sealed-bid solicitation 26P00188 for Advanced Life Support Medications, due April 8, 2026, with an estimated contract value of $40,000.00 and a one-year term. The solicitation required supply of four specific medication line items — Labetalol, Epinephrine, Adenosine, and Diltiazem in stated unit quantities — with nine-month minimum shelf life, ten-day delivery, and full warranty coverage. The bid was sheltered to Small Local Business Enterprises under Tampa's SLBE program with a 5 percent bid discount not to exceed $10,000. The source provides limited geographic spread; Florida emerges as the only state with documented recent activity under this code. Bidders were required to submit OSHA-compliant Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation alongside technical specifications.